跳至主要内容
临床试验/JPRN-jRCT2052190124
JPRN-jRCT2052190124已完成未知

A non-inferiority randomized controlled trial to evaluate the efficacy and safety of automated delivery of three anesthetics using automated delivery system for total intravenous anesthesia with propofol, remifentanil, and rocuronium

Shigemi Kenji0 个研究点目标入组 120 人开始时间: 2020年3月26日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1. Male and female patients over 20 years old at the time of informed consent
  • 2. Patients with ASA physical status of 1, 2, and 3 who are scheduled for surgery under general anesthesia
  • 3. Patients who understand the contents of this study and are willing to provide written informed consent for participation in this study

排除标准

  • 1. Patients with a history of hypersensitive to propofol, remifentanil, rocuronium or sugammadex.
  • 2. Patients who cannot connected BIS Sensor for placement on the forehead.
  • 3. Patients who cannot received rocuronium after first single dose.
  • 4. Patients who cannot measured non-invasive sphygmomanometer.
  • 5. Patients undergoing surgery with hypothermia.
  • 6. Patients undergoing cardiovascular surgery.
  • 7. Patients undergoing surgery with nerve block.
  • 8. Patients who are pregnant or lactating.
  • 9. Patients who participated in another trial within 12 weeks before obtaining informed consent.
  • 10. Patients who are determined not to be eligible for participation in this study by the research director.

研究者

发起方
Shigemi Kenji

相似试验

A controlled trial of automated delivery of three... | 临床试验